Growth Metrics

Biote (BTMD) Cost of Revenue (2021 - 2025)

Biote has reported Cost of Revenue over the past 5 years, most recently at $14.8 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $14.8 million for Q4 2025, up 5.67% from a year ago — trailing twelve months through Dec 2025 was $54.9 million (down 5.63% YoY), and the annual figure for FY2025 was $54.9 million, down 5.63%.
  • Cost of Revenue for Q4 2025 was $14.8 million at Biote, up from $13.5 million in the prior quarter.
  • Over the last five years, Cost of Revenue for BTMD hit a ceiling of $15.8 million in Q2 2023 and a floor of $1.1 million in Q2 2021.
  • Median Cost of Revenue over the past 5 years was $13.9 million (2025), compared with a mean of $12.1 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 1178.28% in 2022 and later dropped 11.39% in 2025.
  • Biote's Cost of Revenue stood at $1.7 million in 2021, then skyrocketed by 816.46% to $15.4 million in 2022, then dropped by 9.2% to $14.0 million in 2023, then increased by 0.24% to $14.0 million in 2024, then increased by 5.67% to $14.8 million in 2025.
  • The last three reported values for Cost of Revenue were $14.8 million (Q4 2025), $13.5 million (Q3 2025), and $13.9 million (Q2 2025) per Business Quant data.